The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase

Summary

Incorporation of factor (F) Va into prothrombinase directs prothrombin activation by FXa through the meizothrombin pathway, characterized by initial cleavage at Arg³²⁰ We have shown that a pentapeptide with the sequence DYDYQ specifically inhibits this pathway. It has been also established that Hir^54–65(SO₃ -) is a specific inhibitor of prothrombinase.To understand the role of FVa within prothrombinase at the molecular level, we have studied thrombin formation by prothrombinase in the presence of various prothrombin-derived fragments alone or in combination. Activation of prethrombin 1 is slow with cleavages at Arg³²⁰ and Arg²⁷¹ occurring with similar rates. Addition of purified fragment 1 to prethrombin 1 accelerates both the rate of cleavage at Arg³²⁰ and thrombin formation.Both reactions were inhibited by Hir^54–65(SO₃ -) while DYDYQ had no significant inhibitory effect on prethrombin 1 cleavage in the absence or presence of fragment 1. Similarly, activation of prethrombin 2 by prothrombinase,is inhibited by Hir54–65(SO3 -), but is not affected by DYDYQ.Addition of purified fragment 1•2 to prethrombin 2 accelerates the rate of cleavage at Arg³²⁰ by prothrombinase. This addition also results in a significant inhibition of thrombin formation by DYDYQ and is concurrent with the elimination of the inhibitory effect of Hir^54–65(SO₃ -) on the same reaction. Finally, a membrane-bound ternary complex composed of prethrombin 2/fragment 1•2/Hir^54–65(SO₃ -) is inhibited by DYDYQ. Altogether,the data demonstrate that membrane- bound fragment 1 is required to promote optimum FVa cofactor activity which in turn is translated by efficient initial cleavage of prothrombin by prothrombinase at Arg³²⁰.

Keywords

Prothrombin - thrombosis - factor Va - blood coagulation

• References

• 1 Kalafatis M. et al. The regulation of clotting factors. Crit Rev Eukar Gene 1997; 7: 241-280.
• 2 Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20-30.
• 3 Mann KG, Bajaj SP, Heldebrant CM. et al. Intermediates of prothrombin activation. Sem Haematol 1973; 6: 479-493.
• 4 Heldebrant CM. et al. The activation of prothrombin. II. Partial reactions, physical and chemical characterization of the intermediates of activation. J Biol Chem 1973; 248: 7149-7163.
• 5 Owen WG. et al. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J Biol Chem 1974; 249: 594-605.
• 6 Esmon CT. et al. The conversion of prothrombin to thrombin. II. Differentiation between thrombin- and factor Xa-catalyzed proteolyses. J Biol Chem 1974; 249: 606-611.
• 7 Esmon CT, Jackson CM. The conversion of prothrombin to thrombin. III. The factor Xa-catalyzed activation of prothrombin. J Biol Chem 1974; 249: 7782-7790.
• 8 Bajaj SP. et al. Prothrombin fragments. Ca2+ binding and activation kinetics. J Biol Chem 1975; 250: 2150-2156.
• 9 Downing MR. et al. Human prothrombin activation. J Biol Chem 1975; 250: 8897-8906.
• 10 Butkowski RJ. et al. Primary structure of human prethrombin 2 and alpha-thrombin. J Biol Chem 1977; 252: 4942-4957.
• 11 Rosing J. et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283.
• 12 Nesheim ME, Mann KG. The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation. J Biol Chem 1983; 258: 5386-5391.
• 13 Krishnaswamy S. et al. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 1987; 262: 3291-3299.
• 14 Brufatto N, Nesheim ME. Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process. J Biol Chem 2003; 278: 6755-6764.
• 15 Nesheim ME. et al. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-10962.
• 16 Krishnaswamy S. Prothrombinase complex assembly. Contributions of protein-protein and proteinmembrane interactions toward complex formation. J Biol Chem 1990; 265: 3708-3718.
• 17 Krishnaswamy S. et al. Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. J Biol Chem 1988; 263: 3823-3834.
• 18 Boskovic DS. et al. Channeling during prothrombin activation. J Biol Chem 2001; 276: 28686-28693.
• 19 Jackson GM. Models for reaction mechanisms in haemostasis – Contributions from the study of prothrombin activation. Thromb Haemost 2007; 98: 24-35.
• 20 Rosing J, Tans G. Meizothrombin, a major product of factor Xa-catalyzed prothrombin activation. Thromb Haemost 1988; 60: 355-360.
• 21 Nesheim ME. et al. Characterization of factor V activation intermediates. J Biol Chem 1984; 259: 3187-3196.
• 22 Suzuki K. et al. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-6564.
• 23 Kane WH, Majerus PW. Purification and characterization of human coagulation factor V. J Biol Chem 1981; 256: 1002-1007.
• 24 Thorelli E. et al. Cleavage requirements of factor V in tissue-factor induced thrombin generation. Thromb Haemost 1998; 80: 92-98.
• 25 Saleh M. et al. The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis. Thromb Haemost 2004; 91: 16-27.
• 26 Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci USA 1988; 85: 2429-2433.
• 27 Hortin GL. Sulfation of tyrosine residues in coagulation factor V. Blood 1990; 76: 946-952.
• 28 Michnick DA. et al. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage. J Biol Chem 1994; 269: 20095-20102.
• 29 Adams TE. et al. The crystal structure of Activated Protein C-inactivated bovine factor Va: Implications for cofactor function. Proc Natl Acad Sci USA 2004; 101: 8918-8923.
• 30 Orban T. et al. Completed three-dimensional model of human coagulation factor Va. Molecular dynamics simulations and structural analyses. Biochemistry 2005; 44: 13082-13090.
• 31 Kalafatis M, Beck DO. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X. Biochemistry 2002; 41: 12715-12728.
• 32 Anderson PJ, Bock PE. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin. J Biol Chem 2003; 278: 44489-44495.
• 33 Anderson PJ. et al. Role of proexosite I in factor Vadependent substrate interactions of prothrombin activation. J Biol Chem 2000; 275: 16435-16442.
• 34 Anderson PJ. et al. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin. J Biol Chem 2003; 278: 44482-44488.
• 35 Beck DO. et al. The contribution of amino acid region ASP695-TYR698 of factor V to procofactor activation and factor Va function. J Biol Chem 2004; 279: 3084-3095.
• 36 Chen L, Rezaie AR. Proexosite-1-dependent recognition and activation of prothrombin by taipan venom. J Biol Chem 2004; 279: 17869-17874.
• 37 Chen L. et al. Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex. J Biol Chem 2003; 278: 27564-27569.
• 38 Bukys MA. et al. A control switch for prothrombinase: characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation. J Biol Chem 2006; 281: 39194-39204.
• 39 Walker RK, Krishnaswamy S. The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis. J Biol Chem 1994; 269: 27441-27450.
• 40 Pieters J. et al. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood 1989; 74: 1021-1024.
• 41 Monteiro RQ, Zingali RB. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation. Thromb Haemost 2002; 87: 288-293.
• 42 Blostein MD. et al. The Gla domain of human prothrombin has a binding site for factor Va. J Biol Chem 2000; 275: 38120-38126.
• 43 Deguchi H. et al. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. Biochem J 1997; 321: 729-735.
• 44 Lentz BR. et al. Phosphatidylserine-containing membranes alter the thermal stability of prothrombin’s catalytic domain: a differential scanning calorimetric study. Biochemistry 1994; 33: 5460-5468.
• 45 Krishnaswamy S, Walker RK. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex. Biochemistry 1997; 36: 3319-3330.
• 46 Myrmel KH. et al. Characteristics of the association between prothrombin fragment 2 and alpha-thrombin. Biochemistry 1976; 15: 1767-1773.
• 47 Esmon CT, Jackson CM. The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. J Biol Chem 1974; 249: 7791-7797.
• 48 Côté HCF. et al. Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A). J Biol Chem 1994; 269: 11374-11380.
• 49 Côté HCF. et al. Functional characterization of recombinant human meizothrombin and Meizothrombin( desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition. J Biol Chem 1997; 272: 6194-6200.
• 50 Stevens WK. et al. Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity. J Biol Chem 1996; 271: 8062-8067.
• 51 Yan SC. et al. Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Biotechnology (NY) 1990; 8: 655-661.
• 52 Nesheim ME. et al. Factor V. Methods Enzymol 1980; 80: 243-275.
• 53 Bukys MA. et al. Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa. J Biol Chem 2005; 280: 27393-27401.
• 54 Barenholz Y. et al. A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 1977; 16: 2806-2910.
• 55 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
• 56 Krishnaswamy S. et al. The binding of activated protein C to factors V and Va. J Biol Chem 1986; 261: 9684-9693.
• 57 Krishnaswamy S. The interaction of human factor VIIa with tissue factor. J Biol Chem 1992; 267: 23696-23706.
• 58 Pryzdial EL, Mann KG. The association of coagulation factor Xa and factor Va. J Biol Chem 1991; 266: 8969-8977.
• 59 Rice P. et al. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet 2000; 16: 276-277.
• 60 Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
• 61 Vijayalakshmi J. et al. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci 1994; 3: 2254-2271.
• 62 Martin PD. et al. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. Structure 1997; 5: 1681-1693.
• 63 Bianchini EP. et al. Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase. Proc Natl Acad Sci USA 2005; 102: 10099-10104.
• 64 Gallivan JP, Dougherty DA. Cation-π interactions in structural biology. Proc Natl Acad Sci USA 1999; 96: 9459-9464.
• 65 Sippl MJ. Recognition of errors in three-dimensional structures of proteins. Proteins 1993; 17: 355-362.
• 66 Laskowski RA. et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993; 26: 283-291.
• 67 Darden T. et al. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. J Chem Phys 1993; 98: 10089-10092.
• 68 Essmann U. et al. A smooth particle mesh Ewald method. J Chem Phys 1995; 103: 8577-8593.
• 69 Van Gunsteren WF, Berendsen HJC. Gromos-87 manual. Biomos BV Nijenborgh. 4, 9747 AG Groningen; The Netherlands: 1987
• 70 Berendsen HJC. et al. GROMACS:A message-passing parallel molecular dynamics implementation. Comp Phys Comm 1995; 91: 43-56.
• 71 Lindahl E. et al. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Mod 2001; 7: 306-317.
• 72 Berendsen HJC. et al. Interaction models for water in relation to protein hydration. Intermolecular Forces. Dordrecht, The Netherlands: 1981: 331-342.
• 73 Betz A, Krishnaswamy S. Regions remote from the site of cleavage determine macromolecular substrate recognition by the prothrombinase complex. J Biol Chem 1998; 273: 10709-10718.
• 74 Yegneswaran S. et al. Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex. J Biol Chem 2004; 279: 49019-49025.
• 75 Yegneswaran S. et al. Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex. J Biol Chem 2003; 278: 33312-33318.
• 76 Billy D. et al. Prothrombin contributes to the assembly of the factor Va-factor Xa complex at phosphatidylserine- containing phospholipid membranes. J Biol Chem 1995; 270: 26883-26889.
• 77 Arni RK. et al. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry 1993; 32: 4727-4737.
• 78 Liaw PCY. et al. Localization of the thrombin-binding domain on prothrombin fragment 2. J Biol Chem 1998; 273: 8932-8939.
• 79 Ni F. et al. Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin. J Biol Chem 1993; 268: 16899-16902.
• 80 Kabis CW. et al. A kinetic model describing the interaction of bovine prothrombin fragment 1 with calcium ions. Thromb Haemost 1985; 53: 19-23.
• 81 Kalafatis M. et al. Structural requirements for expression of factor Va activity. J Biol Chem 2003; 278: 33550-33561.
• 82 Kretz CA. et al. HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase. J Biol Chem 2006; 281: 37477-37485.
• 83 Wei A. et al. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. J Mol Biol 1998; 283: 147-154.
• 84 Krishnaswamy S, Betz A. Exosites determine macromolecular substrate recognition by prothrombinase. Biochemistry 1997; 36: 12080-12086.
• 85 Krishnaswamy S. Exosite-driven substrate specificity and function in coagulation. J Thromb Haemost 2005; 3: 54-67.